Logo

Strata Biosciences Appoints Lane CEO

Dec 18, 1998
Premium

ALAMEDA, Calif.--Strata Bio sciences, a functional genomics company here that uses proprietary technologies combining molecular biology, high-throughput screening, and cell-based models to discover disease causing genes, has hired Douglas Lane as president and CEO. Lane was recently vice-president of genomic research at CapCURE, a foundation seeking cures for prostate cancer. Previously, he was vice-president of corporate development at Hyseq and spent seven years in the position of business development director for SmithKline Beecham where he was instrumental in managing alliances with Human Genome Sciences and the Institute for Genomic Research.

Filed under

Informatics
Breaking News
The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.